technologies.org
HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing: Breakthrough medical platform offers vision of personalized tumor treatments with its novel sonic beam therapy
HistoSonics, developer of a non-invasive robotics platform and novel beam therapy, announced today that it has closed a $54 million Series C financing. The round was led by Varian Medical Systems, …